Precision and Personalized Medicine – Advanced Therapeutics: Strategic Intelligence

All the vital news, analysis, and commentary curated by our industry experts.

$3450

Buy Report Download FREE Resources

Published: February 27, 2026 Report Code: GDHCHT666-TH

Report Overview
Table of Contents

Precision and personalized medicine market analysis: explore gene therapy, cell therapy, biomarkers, and advanced therapeutics trends. Identify opportunities, benchmark leaders, and support strategic decisions with GlobalData insights.

Understand the Future of Precision and Personalized Medicine (PPM)

Precision and personalized medicine is reshaping how diseases are diagnosed, treated, and managed. This report helps you understand where the market is heading and how advanced therapeutics are evolving.

You will gain insight into how gene-modified cell therapies, gene therapy, and other advanced modalities are influencing treatment outcomes. Moreover, the report highlights how healthcare is shifting from reactive care to proactive, targeted intervention.

As a result, you can better assess where the next wave of innovation and investment may emerge.

Report Value Proposition – Why This Matters for You

This report goes beyond describing trends. It helps you interpret what they mean for your business.

You can use it to:

Identify high-growth opportunities in advanced therapeutics
Evaluate competitive positioning across key modalities
Benchmark against global leaders in precision medicine
Support investment, licensing, and partnership decisions
Understand how emerging technologies may impact your pipeline

In addition, the analysis is built on GlobalData’s proprietary datasets and expert insights. It is trusted by Fortune 500 companies and leading governments worldwide.

Key Insights in Gene Therapy, Cell Therapy and Advanced Therapeutics

The report provides detailed analysis across critical areas of precision medicine:

Gene-modified cell therapies are emerging as a cornerstone modality, especially in oncology
Cell therapies are entering a rapid growth phase across both cancer and regenerative medicine
Gene therapies continue to expand beyond blockbuster treatments into broader indications
Antisense oligonucleotides are gaining traction as a scalable and fast-growing modality
Oncolytic viruses show early commercial momentum, although they remain niche

Furthermore, the report explores enabling technologies such as genomics and biomarkers. These are critical for patient stratification and treatment success.

Benchmark Against Global Leaders in Precision Medicine

Understanding what leading companies are doing is essential. Therefore, this report includes case studies and competitive insights to help you benchmark effectively.

You can compare strategies, pipelines, and innovation approaches across global leaders. This may help you refine your own roadmap and identify gaps or opportunities.

Scope

What You Will Learn

The report provides a structured view of the precision medicine landscape, including:

Market overview and growth drivers

Deep dives into gene-modified cell therapies, gene therapies, and cell therapies

Analysis of antisense oligonucleotides and oncolytic viruses

Case studies of real-world applications

Key enabling factors such as genomics and biomarkers

Critical considerations for navigating the CGT market

In addition, the report highlights key risks, challenges, and adoption barriers.

Target Buyers for This Report

This report is designed for decision-makers who need actionable insight:

Heads of Strategy and Corporate Development

R&D and Innovation Leaders

Business Development and Licensing Teams

Healthcare Investors and Analysts

Market Intelligence and Competitive Strategy Teams

C-level executives in pharma, biotech, and healthcare

If you are responsible for growth, investment, or innovation, this report can support your decisions.

How Companies Use This Report

Organizations across the healthcare ecosystem can apply this report in practical ways:

Pharmaceutical companies (e.g., Roche, Novartis, Pfizer): Use it to evaluate pipeline strategy, identify licensing opportunities, and track competing modalities

Biotech firms (e.g., Moderna, BioNTech): Leverage insights to prioritize R&D investments and explore new therapeutic platforms

Healthcare providers and hospital networks: Understand how precision medicine may impact treatment protocols and patient outcomes

Investors and private equity firms: Assess high-growth segments and identify emerging leaders in advanced therapeutics

Diagnostics and genomics companies (e.g., Illumina): Align product development with biomarker and genomics trends

As a result, you can move from insight to action more confidently.

Reasons to Buy

Built on Trusted Data and Expert Analysis

This report is backed by GlobalData’s proprietary research and analyst expertise.

Trusted by Fortune 500 companies and government institutions

Built on robust datasets and industry frameworks

Developed by analysts with deep sector knowledge

Act Now to Stay Ahead in Advanced Therapeutics

The precision and personalized medicine market is evolving quickly. However, early insight can create a competitive advantage.

This report helps you understand where the market is moving and how leading players are positioning themselves.

Therefore, if you are evaluating opportunities in gene therapy, cell therapy, or advanced therapeutics, now is the time to act.

Executive Summary

Introduction

Market Overview

Gene-Modified Cell Therapies

Cell Therapies

Gene Therapies

Antisense Oligonucleotides

Oncolytic Viruses

Case Studies

Important Factors to Consider

– CGT Market

– Genomics

– Biomarkers

Key Takeaways

Appendix

Precision and Personalized Medicine – Advanced Therapeutics: Strategic Intelligence thematic reports

Currency USD

Single User

$3,450

Can be used by individual purchaser only

Undecided about purchasing this report?

Enquire Before Buying Download FREE Resources

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Sample Report

Precision and Personalized Medicine – Advanced Therapeutics: Strategic Intelligence was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

Assess the relevance of the report
Evaluate the quality of the report
Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise. The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS

Related reports

View more Services reports

Pharmaceuticals

New

Reflux Esophagitis (Gastroesophageal Reflux Disease): Market View, Current and Future…

Pharmaceuticals

New

Hepatocellular Carcinoma (HCC): Epidemiology Report and Forecast to 2035

Pharmaceuticals

New

Overweight and Obesity: Epidemiology Report and Forecast to 2035

Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Precision and Personalized Medicine – Advanced Therapeutics: Strategic Intelligence in real time.

Access a live Precision and Personalized Medicine – Advanced Therapeutics: Strategic Intelligence dashboard for 12 months, with up-to-the-minute insights.
Fuel your decision making with real-time deal coverage and media activity.
Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.

Tell me more

Reports

Reports by Sector

Report Type

Precision and Personalized Medicine – Advanced Therapeutics: Strategic Intelligence

Scope

Reasons to Buy

Table of Contents

Undecided about purchasing this report?

Get in touch to find out about multi-purchase discounts

Sample Report

Below is a sample report to understand what you are buying

Related reports